Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study-Reference-Cited by-同舟云学术

Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study

Published:2016-11-08 Issue:12 Volume:14 Page:2394-2401
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Kubota Y.¹²,London S. J.³,Cushman M.⁴,Chamberlain A. M.⁵,Rosamond W. D.⁶,Heckbert S. R.⁷,Zakai N.⁴,Folsom A. R.¹

Affiliation:

1. Division of Epidemiology and Community Health; School of Public Health; University of Minnesota; Minneapolis MN USA

2. Public Health; Department of Social Medicine; Osaka University Graduate School of Medicine; Osaka Japan

3. Department of Health and Human Services; Epidemiology Branch; National Institute of Environmental Health Sciences; National Institutes of Health; Research Triangle Park NC USA

4. Departments of Medicine and Pathology; University of Vermont College of Medicine; Burlington VT USA

5. Department of Health Sciences Research; Mayo Clinic; Rochester MN USA

6. Department of Epidemiology; Gillings School of Global Public Health; University of North Carolina; Chapel Hill NC USA

7. Department of Epidemiology; University of Washington; Seattle WA USA

Funder

Nippon Foundation

National Institute of Environmental Health Sciences

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13525/fullpdf

Reference35 articles.

1. Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD;Ambrosetti;Thromb Res,2003

2. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program;Sidney;Chest,2005

3. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients;Curkendall;Ann Epidemiol,2006

4. Clinical presentation and outcome of venous thromboembolism in COPD;Bertoletti;Eur Respir J,2012

5. COPD and risk of venous thromboembolism and mortality in a general population;Børvik;Eur Respir J,2016

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of factor Xa inhibitors on bleeding risk in patients with respiratory diseases;Scientific Reports;2024-02-19

2. Real-world comparative effectiveness of dalteparin and enoxaparin for venous thromboembolism prophylaxis;Blood Coagulation & Fibrinolysis;2024-02-15

3. Impact of preserved ratio impaired spirometry on coronary artery calcium score progression: a longitudinal cohort study;ERJ Open Research;2023-12-15

4. Lung function, respiratory symptoms and incident venous thromboembolism during a 44-year follow-up;Thrombosis Update;2023-08

5. Secondary polycythemia and venous thromboembolism: a systematic review;F1000Research;2023-06-28